CUTANEOUS SQUAMOUS CELL CARCINOMA
Clinical trials for CUTANEOUS SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug combo tested to shrink tough tumors
Disease control CompletedThis study tested a new combination drug (MK-4280A) to see if it could help people with certain advanced cancers. It involved 163 people with either a type of advanced skin cancer (cSCC) or a type of endometrial cancer that had spread or returned. The goal was to see if the drug …
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Drug shrinks tumors before surgery in skin cancer trial
Disease control CompletedThis study tested whether giving an immunotherapy drug called cemiplimab to patients before surgery could help shrink their advanced skin cancer tumors. The goal was to see if this approach led to better surgical outcomes and longer survival. The trial involved 79 patients with a…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Real-World check on skin cancer drug shows how patients fare
Disease control CompletedThis study observed how well the immunotherapy drug cemiplimab worked for patients with advanced forms of two common skin cancers (squamous cell and basal cell carcinoma) in real-world clinics, not just in a controlled trial. It tracked 287 patients to see how their tumors respon…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New injection tested to shrink skin cancers before surgery
Disease control CompletedThis study tested an experimental drug called cemiplimab, injected directly into skin cancer tumors before surgery. The main goal was to see if this approach was safe and how well patients tolerated it. Researchers also looked at whether the injections could shrink the tumors.
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug duo tested for Tough-to-Treat head and neck cancers
Disease control CompletedThis study tested whether combining two existing cancer drugs, pembrolizumab and cetuximab, could help control advanced head and neck cancer that had returned or spread. It involved 78 patients at four US cancer centers, grouped based on their prior treatments. The main goal was …
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Study asks: how do patients feel about their High-Risk skin cancer care?
Knowledge-focused CompletedThis study aimed to better understand the patient experience for people with a high-risk form of skin cancer on the head or neck. Researchers asked 78 patients to complete surveys about their quality of life, how difficult their treatment decisions were, and how satisfied they we…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Mar 18, 2026 18:25 UTC